HTB: no. 13/14 – HIV and COVID-19: issue 10 (9 December 2020)
9 December 2020. Related: Editorial.
2020
BHIVA 2020 virtual conference
9 December 2020. Related: Conference reports.
Worryingly low HIV knowledge among health workers at London hospital: 80% unaware of U=U, 36% worried about their risk from patients
9 December 2020. Related: Conference reports, HIV prevention and transmission.
12th International Workshop on HIV paediatrics
9 December 2020. Related: Conference reports.
Dolutegravir dosing for infants and young children
9 December 2020. Related: Conference reports, Paediatric care.
EU approves dolutegravir 5 mg dispersible for children older than four weeks
9 December 2020. Related: Antiretrovirals, Paediatric care.
New formulation of dolutegravir will make modern ART available for babies and young children at less than $120 a year
9 December 2020. Related: Antiretrovirals, Treatment access, Paediatric care.
Innovation benefits of cabotegravir LA injections for HIV PrEP will enable a closer FDA review
9 December 2020. Related: HIV prevention and transmission.
World AIDS Day 2020: selected events
9 December 2020. Related: Other news.
Once-monthly oral pill as PrEP against HIV: islatravir study to start in 2021
9 December 2020. Related: HIV prevention and transmission.
High rates of drug resistance and virological failure among adults with HIV admitted to hospital in Malawi
9 December 2020. Related: Drug resistance.
Recent studies on HIV and COVID-19 coinfection
9 December 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Early safety and immune responses in older people using the Oxford vaccine: overall results complicated by dosing error
9 December 2020. Related: COVID-19: vaccine research, COVID-19.
BHIVA statement on HIV positive people and access to COVID vaccines
9 December 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research.
Interim results report 94% efficacy with Moderna/NIH mRNA vaccine: FDA hearing on 17 December
9 December 2020. Related: COVID-19: vaccine research, COVID-19.
HIV risk from some COVID-19 vaccines might be unlikely due to rarity of vector viruses involved
9 December 2020. Related: COVID-19: vaccine research, COVID-19.
JAK inhibitor baricitinib in moderate/severe COVID-19
9 December 2020. Related: COVID-19: investigational drugs, COVID-19.
Hydroxychloroquine fails to prevent COVID-19 or SARS-CoV-2 transmission when used as PEP
9 December 2020. Related: COVID-19: investigational drugs, COVID-19: transmission & prevention, COVID-19.
Hydroxychloroquine has no benefit on symptoms at 14 days
9 December 2020. Related: COVID-19: investigational drugs, COVID-19.
WHO SOLIDARITY study published in NEJM
9 December 2020. Related: COVID-19: investigational drugs, COVID-19.
International COVID-19 study launches in Africa but with drugs that have little chance of working (ANTICOV)
9 December 2020. Related: COVID-19: investigational drugs, COVID-19: research studies, COVID-19.
Serious complications commonly reported three months after recovery from COVID-19
9 December 2020. Related: COVID-19: complications, COVID-19: pathogenesis, COVID-19.
HTB no 13–14 – plus: HIV and COVID-19 bulletin no 10 (9 December 2020)
9 December 2020. Related: PDFs.
HIV in the UK: diagnoses continued to fall during 2019 but 42% are still late
11 November 2020. Related: HIV prevention and transmission.
HTB: no. 12 – HIV and COVID-19: issue 9 (11 November 2020)
11 November 2020. Related: Editorial.
HIV Therapy Glasgow 2020
11 November 2020. Related: Conference reports.
Adverse pregnancy outcomes among Spanish women hospitalised with COVID-19
11 November 2020. Related: Conference reports, Pregnancy, COVID-19: transmission & prevention, COVID-19.
51st World Conference on Lung Health
11 November 2020. Related: Conference reports.
No increase in adverse birth outcomes with IPT-exposure in pregnancy in two African cohorts
11 November 2020. Related: Conference reports, Pregnancy, TB coinfection.
International workshop on clinical pharmacology of HIV, hepatitis, and other antiviral drugs
11 November 2020. Related: Conference reports.
New neonatal liquid formulations of dolutegravir have comparable bioavailability to dispersible paediatric tablet
11 November 2020. Related: Conference reports, Antiretrovirals, Paediatric care, PK and drug interactions.
EMA issues positive opinion to approve cabotegravir LA/rilpivirine LA injections (Vocabria/Rekambys) as new HIV treatment
11 November 2020. Related: Antiretrovirals.
Two-monthly cabotegravir injections prevent HIV infection in African women: HPTN 084 study recommends early unblinding
11 November 2020. Related: HIV prevention and transmission.
AIDS 2020: Virtual online translated resources
11 November 2020. Related: On the web.
COVID-19 antibody testing for HIV positive people in the UK: HIV organisations reverse previous exclusion
11 November 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: diagnostics, COVID-19.
HIV positive people at higher risk of worse outcomes from COVID-19 in UK study
11 November 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Remdesivir given full approval by the US FDA, but on limited data
11 November 2020. Related: COVID-19: investigational drugs, COVID-19.
DSMB stops REGN-COV2 (casirivimab/imdevimab) monoclonal antibody study in people with high-flow oxygen or ventilation: implications for UK RECOVERY study
11 November 2020. Related: COVID-19: investigational drugs, COVID-19.
Monoclonal antibody stopped in ACTIV-3 study: bamlanivimab shows lack of benefit in people hospitalised with COVID-19
11 November 2020. Related: COVID-19: investigational drugs, COVID-19.
Early results report 90% efficacy with from Pfizer/BioNTech COVID vaccine
11 November 2020. Related: Special reports, COVID-19: vaccine research, COVID-19.
Convalescent plasma: randomised controlled study finds no benefit in moderate stage COVID-19
11 November 2020. Related: COVID-19: investigational drugs, COVID-19.
No survival benefit from remdesivir, hydroxychloroquine, lopinavir/r or interferon-β1a in moderate and severe COVID-19: interim results from the WHO SOLIDARITY study
11 November 2020. Related: COVID-19: investigational drugs, COVID-19.
HTB no 12 – plus: HIV and COVID-19 bulletin no 9 (11 November 2020)
11 November 2020. Related: PDFs.
HIV Therapy Glasgow 2020
15 October 2020. Related: Conference reports.
HTB: no. 11 – HIV and COVID-19: issue 8 (14 October 2020)
14 October 2020. Related: Editorial.
In memory: Timothy Ray Brown – the Berlin patient, the first person to be cured of HIV
14 October 2020. Related: In memory.
Capsid inhibitor lenacapavir, dosed six-monthly, has high barrier to drug resistance and no cross-resistance to other classes
14 October 2020. Related: Conference reports, Antiretrovirals.
Single doses of MK-8507 reduce viral load by mean –1.5 log and support once-weekly dosing above 80 mg
14 October 2020. Related: Conference reports, Antiretrovirals.
Weight gain with dolutegravir-based ART in Nigerian cohort
14 October 2020. Related: Conference reports, Side effects.
COVID-19: pathogenesis and treatment
14 October 2020. Related: Conference reports, COVID-19: investigational drugs, COVID-19.
EACS guidelines updated (v.10.1) for Glasgow conference
14 October 2020. Related: Conference reports, Guidelines.
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs
14 October 2020. Related: Conference reports, PK and drug interactions.
FTC exposure higher in young transgender men than cisgender controls
14 October 2020. Related: Conference reports, PK and drug interactions, HIV prevention and transmission.
Levels of long-acting anti-HIV bNAb high in infants after 1 or 2 doses – but not high enough
14 October 2020. Related: Conference reports, Paediatric care, PK and drug interactions, HIV prevention and transmission.
BASHH 2020 PEP guidelines: online for comment
14 October 2020. Related: Guidelines, HIV prevention and transmission.
New insights into elite control of HIV and a possible case of virus clearance
14 October 2020. Related: Cure-related research.
US study of HIV positive people with COVID-19 reports worse outcomes with comorbidities and having a CD4 <200
14 October 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Outcomes from COVID-19 in French cohort of 54 HIV positive people on ART
14 October 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Tocilizumab fails to meet clinical endpoints in randomised COVACTA study: other studies continue
14 October 2020. Related: COVID-19: investigational drugs, COVID-19.
COVID-19 reinfection can occur after varying times and with more severe disease
14 October 2020. Related: COVID-19: transmission & prevention, COVID-19.
Transmission from children to family members in US childcare setting
14 October 2020. Related: COVID-19: transmission & prevention, COVID-19.
BHIVA update guidance for HIV care during second wave of COVID-19
14 October 2020. Related: COVID-19: guidelines, COVID-19.
COVID-19 deaths in children and people <21 years old in the US
14 October 2020. Related: COVID-19: paediatrics, COVID-19.
IDSA guidelines on serologic testing for SARS-CoV-2
14 October 2020. Related: COVID-19: diagnostics, COVID-19.
Long COVID: Mild infection and sustained long-term complications
14 October 2020. Related: COVID-19: pathogenesis, COVID-19.